For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look ...

Orchid Pharma's new Antimicrobial Solutions division aims to achieve a turnover of Rs 300 crore in three years, tackling ...

After achieving about 10 per cent growth last year, the Indian pharmaceuticals sector is again set to log a revenue growth of 8-10 per cent this fiscal, according to a report on Wednesday. The report ...

Indian shares are set to open higher on Friday, as an outsized interest rate reduction by the U.S. Federal Reserve and the ...

The US Biosecure Act aims to prohibit US drugmakers from engaging in business with five Chinese companies after eight years.

The ongoing political unrest in Bangladesh is causing significant disruptions for Indian pharmaceutical exporters and medical ...

The Indian pharmaceutical industry is concerned over the talent gap the sector is facing, particularly in areas like data science, digital marketing, and innovative R&D. The industry is undergoing ...

Drugs and pharmaceutical exports have overtaken gems and jewellery, and chemicals in first five months of the year ...

Chemists’ Association Pune District claims that up to 20 per cent of drugs in the market may be falsified or substandard.

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...